NEWS
- 02.02.2012 San Diego: CalAsia Pharmaceuticals and Professor R. Padmanabhan of Georgetown University announce a collaboration to develop inhibitors of Dengue and West Nile virus proteases.
- 12.07.2011 San Diego: CalAsia and LD Biopharma Have Agreed to Provide Integrated Discovery Services for structure-based and fragment-based drug discovery.
- 08.22.2011 CalAsia and Boston College announce a collaboration to develop novel gluconeogenesis inhibitors to treat metformin intolerant Type II Diabetes patients
- 08.22.2011 Ruo Steensma, PhD joined CalAsia as Head of Chemistry and Business Development
- 03.01.2011 Jeff Stebbins, PhD joined CalAsia as Head of Biology
- 09.10.2010 CalAsia receives a $279,068 grant award to develop selective and dual-acting HSP90 and TRAP1 inhibitors
- 06.07.2010 CalAsia receives a $549,882 grant award to develop novel, selective and potent brain-penetrable small molecule cytosolic Hsp90 inhibitors
- 05.05.2010 CalAsia receives a $201,930 grant award to develop glucose-dependent partial activators of pancreatic glucokinase